Form 4: CITY HOLDING CEO Sells Shares, Discloses Holdings
Insider Transaction Report
CITY HOLDING CO's President & CEO, Charles R. Hageboeck, reported the sale of 1,275 shares of common stock and updated his beneficial ownership, including restricted stock units.
Summary
- Charles R. Hageboeck, President & CEO and a Director of CITY HOLDING CO, reported transactions involving the company's common stock.
- On February 20, 2026, Hageboeck sold 442 shares of common stock at a price of $125 per share.
- On the same date, Hageboeck sold an additional 833 shares of common stock at a price of $125.5 per share.
- Following these transactions, Hageboeck directly beneficially owns 49,084 shares of common stock.
- Hageboeck also indirectly beneficially owns 2,134.2807 shares of common stock through the Company's 401(k) Plan and Trust, as of the December 31, 2025 plan valuation date.
- The filing also details several grants of Restricted Stock Units (RSUs) with various vesting schedules, totaling 6,540 units.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing as slightly negative due to the insider selling by the CEO. While the amount sold is not exceptionally large relative to total holdings, any insider sale can be perceived as a cautious signal by the market, even if it's for routine personal financial management.
Positives
- The CEO continues to hold a substantial number of shares directly (49,084) and indirectly (2,134.2807), aligning his interests with shareholders.
- The disclosure of Restricted Stock Units (RSUs) indicates ongoing long-term incentive compensation for the CEO, totaling 6,540 units across multiple grants.
Negatives
- The sale of 1,275 shares by the President & CEO could be interpreted by some investors as a signal of reduced confidence or a belief that the stock is fully valued.
- While the sales were made at prices of $125 and $125.5, the reason for the sale is not disclosed, which can sometimes lead to speculation.
Risks
- Insider selling, even if for personal financial planning, can sometimes be perceived negatively by the market and may put downward pressure on the stock price.
- The value of the Restricted Stock Units (RSUs) is subject to future stock price performance and continued employment, representing a market risk for the compensation.
Future Outlook
The filing indicates future vesting events for various grants of Restricted Stock Units (RSUs) extending through March 2028, which represent future common stock issuances to the CEO upon satisfaction of vesting conditions.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions. While the sale of shares by a CEO can sometimes be viewed with caution, it is not uncommon for executives to sell shares for personal financial planning, diversification, or tax purposes. The market typically scrutinizes the magnitude and frequency of such sales in relation to the executive's overall holdings and company performance.
Stakeholder Impact
- Shareholders may observe the insider selling activity and consider it in their investment decisions, potentially leading to increased scrutiny of the company's near-term prospects.
- Employees, particularly those with equity compensation, may monitor executive stock transactions as an indicator of management's confidence.
Next Steps
- Continued vesting of various Restricted Stock Unit grants on scheduled dates through March 21, 2028.
Key Dates
| Date | Description |
|---|---|
| 2022-02-24 | First vesting date for one-third of 671 restricted stock units. |
| 2023-02-23 | First vesting date for one-third of 1,330 restricted stock units. |
| 2023-02-24 | Second vesting date for one-third of 671 restricted stock units. |
| 2024-02-22 | First vesting date for one-third of 1,565 restricted stock units. |
| 2024-02-23 | Second vesting date for one-third of 1,330 restricted stock units. |
| 2024-02-24 | Third vesting date for one-third of 671 restricted stock units. |
| 2025-02-22 | Second vesting date for one-third of 1,565 restricted stock units. |
| 2025-02-23 | First vesting date for one-third of 1,627 restricted stock units and third vesting date for one-third of 1,330 restricted stock units. |
| 2025-12-31 | Valuation date for shares held in the 401(k) Plan and Trust. |
| 2026-02-20 | Date of common stock sales by Charles R. Hageboeck. |
| 2026-02-22 | Third vesting date for one-third of 1,565 restricted stock units. |
| 2026-02-23 | Second vesting date for one-third of 1,627 restricted stock units. |
| 2026-02-23 | Signature date of the reporting person's attorney-in-fact. |
| 2026-03-21 | First vesting date for one-third of 1,347 restricted stock units. |
| 2027-02-23 | Third vesting date for one-third of 1,627 restricted stock units. |
| 2027-03-21 | Second vesting date for one-third of 1,347 restricted stock units. |
| 2028-03-21 | Third vesting date for one-third of 1,347 restricted stock units. |
Recommendation
holdA seasoned investor would likely maintain a 'hold' recommendation based solely on this Form 4 filing. While insider selling by the CEO is a data point to note, the transaction volume is not overwhelmingly large compared to the CEO's remaining direct and indirect holdings, nor is it necessarily indicative of a fundamental shift in company outlook. It warrants observation rather than an immediate change in investment stance, as such sales can be for personal liquidity or diversification.
Keywords
CHCO, insider trading, Form 4, stock sale, CEO, restricted stock units, beneficial ownership, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.